SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Aziz Mottiwala, vice president of marketing at Allergan, discusses the company’s “franchise approach” to the glaucoma space in which it would like to ensure it has a full complement of pharmaceutical and surgical device options for treating glaucoma.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/p5xgrv/age_related) has announced the addition of the “Age Related Macular Degeneration – Pipeline Review, H2 2015” report to their offering. This report provides…
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (“Second Sight” or “the Company”) (Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, today announced plans to expand into South America by signing an exclusive agreement with Tecnosalud S.A. (“Tecnosalud”) to distribute the Argus® II Retinal Prosthesis System (“Argus II”) in Argentina. “We are excited to partner with Tecnosalud for our expans
MIAMI — Harry W. Flynn Jr., MD, discussed the newly published and continuing trials of the Diabetic Retinopathy Clinical Research Network at Angiogenesis, Exudation, and Degeneration 2016.Protocol S, which was recently published, showed that intravitreal Lucentis (ranibizumab, Genentech) was not inferior to panretinal photocoagulation for diabetic macular edema and resulted in better visual acuity over 2 years. The ranibizumab group had a higher chance of a 10-letter score improvement or better, while the PRP group had a higher chance of visual acuity worsening by 10 letters or more, as well (Read more...)
WAIKOLOA, Hawaii — At Hawaiian Eye, Con Moshegov, MD, discusses how patients can benefit from the Glaukos iStent device before cataract surgery.
The U.S. Senate Committee on Health, Education, Labor and Pensions will consider seven bipartisan bills on biomedical innovation tomorrow, Feb. 9, at the first of three executive sessions.“Senators and staff on our committee have been working together throughout 2015 to produce a number of bipartisan pieces of legislation that are ready for the full committee to consider,” Committee Chairman Sen. Lamar Alexander, R-Tenn., said in a press release. “The House has completed its work on the 21st Century Cures Act. The president has announced his support for a precision medicine (Read more...)